The prognostic value of CYP2C subfamily genes in hepatocellular carcinoma

Cancer Medicine
Xiangkun WangTao Peng

Abstract

Cytochrome P2C (CYP2C) subfamily members (CYP2C8, CYP2C9, CYP2C18, and CYP2C19) are known to participate in clinical drug metabolism. However, the association between CYP2C subfamily members and hepatocellular carcinoma (HCC) remains unclear. This study investigated the prognostic value of CYP2C subfamily gene expression levels with HCC prognosis. Data of 360 HCC patients in The Cancer Genome Atlas database and 231 in the Gene Expression Omnibus database were analyzed. Kaplan-Meier analysis and a Cox regression model were used to ascertain overall survival and recurrence-free survival, and to calculate median survival time using hazard ratios (HR) and 95% confidence intervals (CI). In TCGA database, low expression of CYP2C8, CYP2C9, and CYP2C19 in tumor tissue was associated with a short median survival time (all crude P = 0.001, adjusted P = 0.004, P = 0.047, and P = 0.020, respectively). In TCGA database, joint effects analysis of the combinations of CYP2C8 and CYP2C9, CYP2C8 and CYP2C19, and CYP2C9 and CYP2C19 revealed that high expression of two genes (group 4; group IV, group d) was associated with a reduced risk of death as compared to low expression (group 1, group I, and group a) (adjusted P = 0.005, P = 0.013, and P = ...Continue Reading

References

Aug 1, 1995·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·M ShermanC Lee
Dec 1, 1994·Pharmacogenetics·J A Goldstein, S M de Morais
Aug 26, 1998·Biochemical Pharmacology·T KubotaK Chiba
Feb 16, 2000·Pharmacology & Therapeutics·C Hiemke, S Härtter
Jun 8, 2004·Current Drug Metabolism·Jose A G Agundez
Sep 17, 2004·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·K TougouA Nakamura
Feb 24, 2006·Journal of Clinical Pharmacology·Harry V Gelboin, Kristopher Krausz
Jul 27, 2006·Basic & Clinical Pharmacology & Toxicology·Tiina JaakkolaJanne T Backman
Sep 2, 2006·Toxicological Sciences : an Official Journal of the Society of Toxicology·Tony K L KiangThomas K H Chang
Sep 14, 2006·The Pharmacogenomics Journal·S V VormfeldeJ Brockmöller
Oct 6, 2006·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Tomoko AkutsuKan Chiba
Mar 22, 2007·World Journal of Gastroenterology : WJG·I BergheimA Parlesak
Jun 20, 2007·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Alison E Aitken, Edward T Morgan
Aug 13, 2008·Analytical and Bioanalytical Chemistry·Ulrich M ZangerMatthias Schwab
Jan 10, 2009·Nature Protocols·Da Wei HuangRichard A Lempicki
Aug 5, 2009·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Craig D FisherNathan J Cherrington
Aug 27, 2009·JAMA : the Journal of the American Medical Association·Alan R ShuldinerPaul A Gurbel
May 4, 2010·Pharmacogenetics and Genomics·Eline M RodenburgBruno H Ch Stricker
Feb 8, 2011·CA: a Cancer Journal for Clinicians·Ahmedin JemalDavid Forman
Apr 27, 2012·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Edoardo G GianniniUNKNOWN Italian Liver Cancer (ITA.LI.CA) group
Dec 27, 2012·Clinical Pharmacology and Therapeutics·C O MusumbaM Pirmohamed
Feb 16, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·D L HertzE C Dees
Nov 28, 2013·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Roongruedee ChaiteerakijLewis R Roberts
Jan 15, 2014·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Hong WangWenhui Lou
Feb 11, 2014·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Fei YanXing-Hua Li
Jul 16, 2014·International Journal of Molecular Medicine·Wanjun LiuHesong Zeng
Dec 17, 2014·Pharmacogenomics·Virginia BosóSalvador F Aliño
Oct 21, 2015·Biopreservation and Biobanking·Latarsha J CarithersUNKNOWN GTEx Consortium
Jan 26, 2016·CA: a Cancer Journal for Clinicians·Wanqing ChenJie He
Aug 12, 2016·Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology·Wei JingJiancheng Tu
Oct 28, 2016·Journal of Hepatocellular Carcinoma·Julius BaloghHoward P Monsour

❮ Previous
Next ❯

Datasets Mentioned

BETA
GSE14520

Software Mentioned

SPSS
Cytoscape
GraphPad
DAVID
Search Tool for the Retrieval
GraphPad Prism
R

Related Concepts

Related Feeds

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.